<code id='8DB8392FE4'></code><style id='8DB8392FE4'></style>
    • <acronym id='8DB8392FE4'></acronym>
      <center id='8DB8392FE4'><center id='8DB8392FE4'><tfoot id='8DB8392FE4'></tfoot></center><abbr id='8DB8392FE4'><dir id='8DB8392FE4'><tfoot id='8DB8392FE4'></tfoot><noframes id='8DB8392FE4'>

    • <optgroup id='8DB8392FE4'><strike id='8DB8392FE4'><sup id='8DB8392FE4'></sup></strike><code id='8DB8392FE4'></code></optgroup>
        1. <b id='8DB8392FE4'><label id='8DB8392FE4'><select id='8DB8392FE4'><dt id='8DB8392FE4'><span id='8DB8392FE4'></span></dt></select></label></b><u id='8DB8392FE4'></u>
          <i id='8DB8392FE4'><strike id='8DB8392FE4'><tt id='8DB8392FE4'><pre id='8DB8392FE4'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:51324
          Teladoc website -- health tech coverage from STAT
          Adobe

          Virtual care company Teladoc has a new chief executive officer following the abrupt departure of its longtime leader in April.

          Chuck Divita, who took on the role Monday, previously led the commercial markets business at GuideWell, the parent company of health plan Florida Blue. He was also previously chief financial officer at FPIC Insurance Group, a publicly traded insurance company focused on medical liability.

          advertisement

          Board chair David Snow said in a release that Divita’s health care experience and tenure at a public company made him an attractive candidate. Divita has also joined Teladoc’s board of directors.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          In rare move, senator releases unverified FBI source report alleging Biden bribe
          In rare move, senator releases unverified FBI source report alleging Biden bribe

          4:19Sen.ChuckGrassleyisseenoutsidetheRepublicansenateluncheonattheCapitolastheSenateworksonthedebtli

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

          Aneggisexaminedduringtheprocessofinvitrofertilization.Gameto,abiotechstartup,hasdevelopedaproductcal